This brand name is authorized in Tunisia
The drug ACTOPRIL contains one active pharmaceutical ingredient (API):
UNII 9G64RSX1XD - CAPTOPRIL
Captopril is a highly specific, competitive inhibitor of angiotensin-I converting enzyme (ACE inhibitors). Inhibition of ACE results in decreased plasma angiotensin-II, which leads to decreased vasopressor activity and to reduced aldosterone secretion. In patients with hypertension, captopril causes a reduction in supine and erect blood pressure, without inducing any compensatory increase in heart rate, nor water and sodium retention.
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
|C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
This drug has been assigned below unique identifiers within the countries it is being marketed:
|Direction de la Pharmacie et du Médicament
|Identifier(s): 9293111, 9293112, 9293113H, 9293114H, 9293115
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.